01683nam a22004457a 4500
190621s20192019 xxu||||| |||| 00| 0 eng d
1878-0938
Ovid MEDLINE(R)
31109877
Expanding the Treatment of Calcified Lesions.
Response to the letter by Bilazarian et al. regarding the article, "Adverse events and modes of failure related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database".
Cardiovascular Revascularization Medicine. 20(7):622-623, 2019 07.
Cardiovasc Revasc Med. 20(7):622-623, 2019 07.
Cardiovasc Revasc Med. 2019 May 13
Cardiovascular revascularization medicine : including molecular interventions
2019
FY2020
aheadofprint
ppublish
2019-06-21
Cardiovascular Revascularization Medicine. 2019 May 13
FY2019
English
*Atherectomy, Coronary
*Percutaneous Coronary Intervention
*Thrombosis
Adenosine Monophosphate/aa [Analogs & Derivatives]
Humans
Stents
MedStar Heart & Vascular Institute
Letter
Chen, Yuefeng
Khalid, Nauman
Rogers, Toby
Shlofmitz, Evan
Waksman, Ron
Chen Y, Khalid N, Rogers T, Shlofmitz E, Waksman R
https://dx.doi.org/10.1016/j.carrev.2019.05.010
https://dx.doi.org/10.1016/j.carrev.2019.05.010
ART
Article
0
0
0
0
Article
authcat
authcat
2019-06-21
0
31109877
31109877
2019-06-21
2019-06-21
ART
4325
4325